Starton Holdings, Inc.

Overview

Compare with another stock.

• TickerSTA¹
• IndustryPharmaceutical Preparations¹
• HeadquartersParamus, New Jersey¹
• Incorporated inDE²
• Business address215 College Road, Suite 300, Paramus, Nj 07652²

See how the biggest companies compare on our leaderboards

Calendar

Drug trials and FDA: coming up

1. May 31, 2027Phase 1/2 trial readout expected Phase 1/2 trial of Lenalidomide and Lenalidomide 25 MG Oral Capsule in Multiple Myeloma: primary completion expected May 31, 2027 (ClinicalTrials.gov NCT06087653).³

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Filings

8 filings to the SEC since October 2021: 8 other. The latest 8:

1. Jul 13, 2026S-1/A REGISTRATION STATEMENT EDGAR
2. Jun 9, 2026S-1/A REGISTRATION STATEMENT EDGAR
3. Apr 7, 2026S-1/A REGISTRATION STATEMENT EDGAR
4. Mar 13, 2026S-1/A REGISTRATION STATEMENT EDGAR
5. Jan 30, 2026S-1/A REGISTRATION STATEMENT EDGAR
6. Dec 11, 2025S-1 REGISTRATION STATEMENT EDGAR
7. Mar 21, 2025DRS/A EDGAR
8. Dec 31, 2024DRS EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How Starton Holdings, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARStarton Holdings, Inc.¹
• CIK0002049977
• Employer ID (EIN)33-2448745¹
• Incorporated inDelaware¹
• Fiscal year endsMarch 31¹
• Industry code (SIC)2834 Pharmaceutical Preparations¹
• SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
• Business address215 College Road, Suite 300, Paramus, NJ 07652¹
• Phone800-449-5405¹
• On EDGAR sinceDec 31, 2024¹
• Filings8 in all: S-1/A (5), DRS (1), DRS/A (1), S-1 (1)¹